Literature DB >> 31092566

Human Papillomavirus 16 Capsids Mediate Nuclear Entry during Infection.

Patricia M Day1, Andrea S Weisberg2, Cynthia D Thompson3, Michelle M Hughes3, Yuk Ying Pang3, Douglas R Lowy3, John T Schiller3.   

Abstract

Infectious human papillomavirus 16 (HPV16) L1/L2 pseudovirions were found to remain largely intact during vesicular transport to the nucleus. By electron microscopy, capsids with a diameter of 50 nm were clearly visible within small vesicles attached to mitotic chromosomes and to a lesser extent within interphase nuclei, implying nuclear disassembly. By confocal analysis, it was determined that nuclear entry of assembled L1 is dependent upon the presence of the minor capsid protein, L2, but independent of encapsidated DNA. We also demonstrate that L1 nuclear localization and mitotic chromosome association can occur in vivo in the murine cervicovaginal challenge model of HPV16 infection. These findings challenge the prevailing concepts of PV uncoating and disassembly. More generally, they document that a largely intact viral capsid can enter the nucleus within a transport vesicle, establishing a novel mechanism by which a virus accesses the nuclear cellular machinery.IMPORTANCE Papillomaviruses (PVs) comprise a large family of nonenveloped DNA viruses that include HPV16, among other oncogenic types, the causative agents of cervical cancer. Delivery of the viral DNA into the host cell nucleus is necessary for establishment of infection. This was thought to occur via a subviral complex following uncoating of the larger viral capsid. In this study, we demonstrate that little disassembly of the PV capsid occurs prior to nuclear delivery. These surprising data reveal a previously unrecognized viral strategy to access the nuclear replication machinery. Understanding viral entry mechanisms not only increases our appreciation of basic cell biological pathways but also may lead to more effective antiviral interventions.
Copyright © 2019 American Society for Microbiology.

Entities:  

Keywords:  HPV; nuclear import/export; papillomavirus; uncoating; vesicle

Mesh:

Substances:

Year:  2019        PMID: 31092566      PMCID: PMC6639283          DOI: 10.1128/JVI.00454-19

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  49 in total

1.  Nuclear import of HPV11 L1 capsid protein is mediated by karyopherin alpha2beta1 heterodimers.

Authors:  E Merle; R C Rose; L LeRoux; J Moroianu
Journal:  J Cell Biochem       Date:  1999-09-15       Impact factor: 4.429

2.  The minor capsid protein L2 contributes to two steps in the human papillomavirus type 31 life cycle.

Authors:  Sigrid C Holmgren; Nicole A Patterson; Michelle A Ozbun; Paul F Lambert
Journal:  J Virol       Date:  2005-04       Impact factor: 5.103

3.  Cleavage of the papillomavirus minor capsid protein, L2, at a furin consensus site is necessary for infection.

Authors:  Rebecca M Richards; Douglas R Lowy; John T Schiller; Patricia M Day
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-23       Impact factor: 11.205

4.  Hybrid papillomavirus L1 molecules assemble into virus-like particles that reconstitute conformational epitopes and induce neutralizing antibodies to distinct HPV types.

Authors:  N D Christensen; N M Cladel; C A Reed; L R Budgeon; M E Embers; D M Skulsky; W L McClements; S W Ludmerer; K U Jansen
Journal:  Virology       Date:  2001-12-20       Impact factor: 3.616

5.  Establishment of papillomavirus infection is enhanced by promyelocytic leukemia protein (PML) expression.

Authors:  Patricia M Day; Carl C Baker; Douglas R Lowy; John T Schiller
Journal:  Proc Natl Acad Sci U S A       Date:  2004-09-21       Impact factor: 11.205

6.  Reactivity of human sera in a sensitive, high-throughput pseudovirus-based papillomavirus neutralization assay for HPV16 and HPV18.

Authors:  Diana V Pastrana; Christopher B Buck; Yuk-Ying S Pang; Cynthia D Thompson; Philip E Castle; Peter C FitzGerald; Susanne Krüger Kjaer; Douglas R Lowy; John T Schiller
Journal:  Virology       Date:  2004-04-10       Impact factor: 3.616

7.  Arrangement of L2 within the papillomavirus capsid.

Authors:  Christopher B Buck; Naiqian Cheng; Cynthia D Thompson; Douglas R Lowy; Alasdair C Steven; John T Schiller; Benes L Trus
Journal:  J Virol       Date:  2008-03-26       Impact factor: 5.103

8.  Neutralization of human papillomavirus with monoclonal antibodies reveals different mechanisms of inhibition.

Authors:  Patricia M Day; Cynthia D Thompson; Christopher B Buck; Yuk-Ying S Pang; Douglas R Lowy; John T Schiller
Journal:  J Virol       Date:  2007-06-06       Impact factor: 5.103

9.  Efficient intracellular assembly of papillomaviral vectors.

Authors:  Christopher B Buck; Diana V Pastrana; Douglas R Lowy; John T Schiller
Journal:  J Virol       Date:  2004-01       Impact factor: 5.103

10.  Genital transmission of HPV in a mouse model is potentiated by nonoxynol-9 and inhibited by carrageenan.

Authors:  Jeffrey N Roberts; Christopher B Buck; Cynthia D Thompson; Rhonda Kines; Marcelino Bernardo; Peter L Choyke; Douglas R Lowy; John T Schiller
Journal:  Nat Med       Date:  2007-07-01       Impact factor: 53.440

View more
  13 in total

1.  Human Papillomavirus infection requires the CCT Chaperonin Complex.

Authors:  Marina Bugnon Valdano; Paola Massimi; Justyna Broniarczyk; David Pim; Michael Myers; Daniela Gardiol; Lawrence Banks
Journal:  J Virol       Date:  2021-03-17       Impact factor: 5.103

2.  Cell-penetrating peptide inhibits retromer-mediated human papillomavirus trafficking during virus entry.

Authors:  Pengwei Zhang; Ruben Moreno; Paul F Lambert; Daniel DiMaio
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-02       Impact factor: 11.205

Review 3.  The long and winding road: human papillomavirus entry and subcellular trafficking.

Authors:  Michelle A Ozbun; Samuel K Campos
Journal:  Curr Opin Virol       Date:  2021-08-17       Impact factor: 7.121

Review 4.  The emerging roles of retromer and sorting nexins in the life cycle of viruses.

Authors:  Yue Lu; Ping He; Yuxuan Zhang; Yongwen Ren; Leiliang Zhang
Journal:  Virol Sin       Date:  2022-05-02       Impact factor: 6.947

Review 5.  Papillomaviruses Go Retro.

Authors:  Jian Xie; Pengwei Zhang; Mac Crite; Daniel DiMaio
Journal:  Pathogens       Date:  2020-04-07

6.  TBC1D5-Catalyzed Cycling of Rab7 Is Required for Retromer-Mediated Human Papillomavirus Trafficking during Virus Entry.

Authors:  Jian Xie; Erin N Heim; Mac Crite; Daniel DiMaio
Journal:  Cell Rep       Date:  2020-06-09       Impact factor: 9.423

7.  Vesicular trafficking permits evasion of cGAS/STING surveillance during initial human papillomavirus infection.

Authors:  Brittany L Uhlorn; Robert Jackson; Shuaizhi Li; Shauna M Bratton; Koenraad Van Doorslaer; Samuel K Campos
Journal:  PLoS Pathog       Date:  2020-11-30       Impact factor: 6.823

Review 8.  Update on human papillomavirus - Part II: complementary diagnosis, treatment and prophylaxis.

Authors:  Marcelo Grossi Araújo; Geraldo Magela Magalhães; Lucas Campos Garcia; Érica Cristina Vieira; Maria de Lourdes Ribeiro de Carvalho-Leite; Antônio Carlos Martins Guedes
Journal:  An Bras Dermatol       Date:  2021-02-16       Impact factor: 1.896

Review 9.  The Role of Promyelocytic Leukemia Nuclear Bodies During HPV Infection.

Authors:  Lucile G Guion; Martin Sapp
Journal:  Front Cell Infect Microbiol       Date:  2020-02-19       Impact factor: 5.293

10.  p120 catenin recruits HPV to γ-secretase to promote virus infection.

Authors:  Mara Calypso Harwood; Allison Jade Dupzyk; Takamasa Inoue; Daniel DiMaio; Billy Tsai
Journal:  PLoS Pathog       Date:  2020-10-21       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.